HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors.
about
Influences of BRAF Inhibitors on the Immune Microenvironment and the Rationale for Combined Molecular and Immune Targeted Therapy.Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.Molecular mechanisms of HLA class I-mediated immune evasion of human tumors and their role in resistance to immunotherapies.Modulation of cabozantinib efficacy by the prostate tumor microenvironment.Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors.
P2860
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
HLA class I downregulation is ...... resistance to BRAF inhibitors.
@ast
HLA class I downregulation is ...... resistance to BRAF inhibitors.
@en
type
label
HLA class I downregulation is ...... resistance to BRAF inhibitors.
@ast
HLA class I downregulation is ...... resistance to BRAF inhibitors.
@en
prefLabel
HLA class I downregulation is ...... resistance to BRAF inhibitors.
@ast
HLA class I downregulation is ...... resistance to BRAF inhibitors.
@en
P2093
P2860
P50
P356
P1476
HLA class I downregulation is ...... resistance to BRAF inhibitors
@en
P2093
Elvira Favoino
Francesca Trecroci
Klas Kärre
Laura Orgiano
Soldano Ferrone
Thomas Tan
P2860
P304
P356
10.1002/EJI.201445289
P407
P50
P577
2015-12-20T00:00:00Z